๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Pseudohyperkalemia and platelet count in thrombocythemia

โœ Scribed by Jan J. Michels

Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
239 KB
Volume
42
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Thrombotic complications in essential th
Thrombotic complications in essential thrombocythemia with relatively low platelet counts
โœ Regev, Arie; Stark, Pinhas; Blickstein, Dorit; Lahav, Meir ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 60 KB ๐Ÿ‘ 1 views

Essential thrombocythemia (ET) is often associated with thrombotic and hemorrhagic complications, mostly at platelet counts exceeding 600 ร— 10 9 /L. There are, however, a few reports of such complications in ET at considerably lower platelet levels and the therapeutic approach to affected patients w

Strong inverse correlation between serum
Strong inverse correlation between serum TPO level and platelet count in essential thrombocythemia
โœ Tomita, Naoto; Motomura, Shigeki; Sakai, Rika; Fujimaki, Katsumichi; Tanabe, Jui ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 135 KB ๐Ÿ‘ 1 views

Serum thrombopoietin (TPO) levels in 50 essential thrombocythemia (ET) patients were measured using a highly sensitive sandwich ELISA. In nine cases, TPO levels were measured at two points with different platelet counts. ET patients showed significantly higher serum TPO levels (n = 59, 2.70 ยฑ 2.74 f

Apheresis platelets: Emerging issues rel
Apheresis platelets: Emerging issues related to donor platelet count, apheresis platelet yield, and platelet transfusion dose
โœ Lawrence Tim Goodnough; David Kuter; Jeffrey McCullough; Mark E. Brecher ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 147 KB ๐Ÿ‘ 1 views

Emerging issues in stimulating apheresis platelet donors with platelet growth factors, the relative costs of apheresis and random donor platelet concentrates, optimal platelet transfusion dose, and leucoreduction of platelet products have caused renewed debate regarding apheresis products vs. random